CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information
edit

Websiteeigerbio.com
CategoryBioTech
Emailinfo@eigerbio.com
Employees
DescriptionHepatitis treatments

Offices
edit

Former People
edit

Wenjin Yang
VP, Chemistry

Funding
edit

TOTAL $7.1M
FUNDING TOTAL $7.1M
Series A, 2/09
InterWest Partners
Vivo Ventures
$7.1M

Tags
edit

Eiger BioPharmaceuticals
edit

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Recent Milestones
edit

Videos

Screenshots
edit

Sources

  1. Eiger snaps up $7.1M to treat hepatitis (venturebeat.com) [edit]
Edit This Page
Last Edited 5/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links
edit

CrunchBase API

JSON Representation of this page.
More API docs »

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy